03 Jun 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/bold-therapeutics-announces-positive-phase-2-safety-and-efficacy-results-for-bold-100-in-advanced-metastatic-biliary-tract-and-gastric-cancers-at-asco-2024-302161951.html
LOOKING FOR A SUPPLIER?